CN

R&D / R&D

R&D

Dongcheng Pharmaceutical Innovation Institute

In order to accelerate the implementation of the innovation and R&D development strategy, as the top designer of scientific and technological innovation, Dongcheng Pharmaceutical Innovation Institute will lead the Group’s technological innovation and R&D, center on the core issues of the industrial technology innovation, strengthen the technological innovation and joint research, speed up the breakthrough in the major common technical difficulties in the industry, and enable all business sector of the Group to become industry leaders and technological pacesetters. 

Global Heparin Specialist, China’s Nuclide Drug Leader

Dongcheng Pharmaceutical will deepen the resource integration, optimize the industrial structure, continuously improve the innovation capability and core competitiveness of the enterprise, aim at the goal of “Global Heparin Specialist, China’s Nuclide Drug Leader”, and advance towards growing into a pharmaceutical enterprise that is leading in the specialized domain and continues to create superior value.

Tel:86-0535-6391521\6391522
Email:zxu@dcb-group.com
Add:No.7 ChangBaiShan Road, Yantai Development Zone, ShanDong, China
About Us
Company Profile
Chairman Address
Honors of Dongcheng
Evolutional History
Development Strategy
Corporate Culture
Subsidiaries
Contact Us
News
Group News
Media Coverage
Products
API Series
Preparation Series
Nuclide Drug Series
Health Care Business
R&D
Technology Platform
Honors and Qualifications
Advanced Equipment
HR
Talent Concepts
Talent Development
Talent Recruitment
Jobs
IR
Instant Quotes
Regular Reports
Investor Services
Responsibility
Social Welfare
Safety & Environmental Protection
Occupational Health
COPYRIGHT 2020 Yantai Dongcheng Pharmaceutical Group Co., Ltd. All rights reserved 魯ICP備18035060號-1
陌生人揉捏花蒂舒服享受